Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 7, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jay Olson Maintained (BIIB) at Buy with Decreased Target to $290 on, Aug 7th, 2023
Jay Olson of Oppenheimer, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $360 to $290 on, Aug 7th, 2023.
Jay has made no other calls on BIIB in the last 4 months.
There are 16 other peers that have a rating on BIIB. Out of the 16 peers that are also analyzing BIIB, 3 agree with Jay's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $268 on, Wednesday, July 26th, 2023
- Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $320 on, Thursday, May 4th, 2023
- Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $282 on, Wednesday, April 26th, 2023
These are the ratings of the 13 analyists that currently disagree with Jay
- Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $323 on, Monday, July 31st, 2023
- George Farmer of "Scotiabank" Initiated at Buy and Held Target at $327 on, Thursday, July 27th, 2023
- Evan Seigerman of "BMO Capital" Maintained at Buy with Decreased Target to $347 on, Wednesday, July 26th, 2023
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $325 on, Wednesday, July 26th, 2023
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $363 on, Wednesday, July 26th, 2023
- Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $320 on, Tuesday, July 25th, 2023
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $350 on, Monday, June 12th, 2023
- Carter Gould of "Barclays" Maintained at Buy on, Thursday, June 8th, 2023
- Brian Skorney of "Baird" Reiterated at Buy and Held Target at $340 on, Wednesday, June 7th, 2023
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $360 on, Thursday, June 1st, 2023
- Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $350 on, Thursday, May 11th, 2023
- Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Increased Target to $350 on, Monday, May 1st, 2023
- Matthew Korn of "Morgan Stanley" Maintained at Buy with Decreased Target to $349 on, Wednesday, April 12th, 2023
